Parkside Financial Bank & Trust - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$2,996
+68.3%
140
+218.2%
0.00%
Q1 2023$1,780
-13.0%
440.0%0.00%
-100.0%
Q4 2022$2,047
-31.8%
44
-25.4%
0.00%0.0%
Q3 2022$3,00059
+2850.0%
0.00%
Q2 2022$0
-100.0%
2
-96.7%
0.00%
-100.0%
Q1 2022$4,000
-20.0%
61
-7.6%
0.00%0.0%
Q4 2021$5,000
+25.0%
660.0%0.00%0.0%
Q3 2021$4,000
+33.3%
66
-2.9%
0.00%0.0%
Q2 2021$3,0000.0%68
+9.7%
0.00%0.0%
Q1 2021$3,000
+200.0%
62
+129.6%
0.00%
Q4 2020$1,000
-50.0%
27
-35.7%
0.00%
-100.0%
Q3 2020$2,0000.0%420.0%0.00%0.0%
Q2 2020$2,0000.0%420.0%0.00%0.0%
Q1 2020$2,000
+100.0%
42
+121.1%
0.00%
Q4 2019$1,000
-50.0%
19
-26.9%
0.00%
-100.0%
Q3 2019$2,0000.0%260.0%0.00%0.0%
Q2 2019$2,0000.0%260.0%0.00%0.0%
Q1 2019$2,000
+100.0%
26
+100.0%
0.00%
Q4 2018$1,0000.0%130.0%0.00%
Q3 2018$1,000
-50.0%
130.0%0.00%
-100.0%
Q2 2018$2,000
+100.0%
130.0%0.00%
Q1 2018$1,0000.0%130.0%0.00%
Q4 2017$1,0000.0%130.0%0.00%
Q3 2017$1,000130.0%0.00%
Q2 2017$0130.0%0.00%
Q1 2017$0130.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 476,042$45,472,00012.29%
Stonepine Capital Management, LLC 60,840$5,811,0003.34%
ACUTA CAPITAL PARTNERS, LLC 61,000$5,827,0002.77%
Virtus ETF Advisers LLC 10,634$1,016,0002.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,000$5,827,0002.15%
ARMISTICE CAPITAL, LLC 372,000$35,533,0001.94%
Matarin Capital Management, LLC 209,403$20,002,0001.46%
Monashee Investment Management LLC 50,000$4,776,0001.10%
Granahan Investment Management 151,322$14,454,0000.78%
ALGERT GLOBAL LLC 13,186$1,260,0000.72%
View complete list of ENANTA PHARMACEUTICALS INC shareholders